Papers to Appear in Forthcoming Issues

Cross-Reactivity of T-Cell Clones Specific for Altered Peptide Ligands of Myelin Basic Protein. Lara J. Ausubel, Katarzyna D. Bieganowska, and David A. Hafler. (Received 10/12/98; accepted 12/21/98.) ass I Molecules on CD4 T Cells Regulate Receptor-Mediated Activation Signals. Zhi-qin Wang, Abhijit S. Bapat, Valia Trejo, Thorsten Orlikowsky, Robert S. Mittler, and Michael K. Hoffmann. (Received 8/26/98; accepted 1/4/99.) ential Induction of TNF-α and IL-1β and Inhibition of IL-10 Secretion by Human Peripheral Blood Monocytes by Synthetic Aza–Alkyl Lysophospholipids. Xiao-Hu Gan and Benjamin Bonavida. (Received 7/21/98; accepted 1/6/99.) bacterium parvum-andMycobacterium bovisBacillus Calmette and Guerin-Induced Granuloma Formation in Mice Lacking CD4 and CD8. Giorgio Senaldi, Christine L. Shaklee, Tak W. Mak, and Thomas R. Ulich. (Received 9/15/98; accepted 1/7/99.) Leukemia Virus Transmembrane Protein gp30 Physically Associates with the Down-Regulatory Phosphatase SHP-1. Glenn H. Cantor, Suzanne M. Pritchard, Oto Orlik, Gary A. Splitter, William C. Davis, and Raymond Reeves. (Received 4/29/98; accepted 2/4/99.) n Kinase C-θ (PKCθ) Distribution Analysis in Hematopoietic Cells: Proliferating T Cells Exhibit High Proportions of PKCθ in the Particulate Fraction. Nahum Meller, Yair Elitzur, and Noah Isakov. (Received 9/29/98; accepted 2/15/99.) tive Effect of NK1.1+T Cells as Well as NK Cells against Intraperitoneal Tumors in Mice. Toshihiko Kawamura, Shuhji Seki, Kazuyoshi Takeda, Junichi Narita, Yusuke Ebe, Makoto Naito, Hoshio Hiraide, and Toru Abo. (Received 11/23/98; accepted 2/15/99.)